Literature DB >> 10551782

Enhanced splicing of the first intron from the gonadotropin-releasing hormone (GnRH) primary transcript is a prerequisite for mature GnRH messenger RNA: presence of GnRH neuron-specific splicing factors.

J Y Seong1, S Park, K Kim.   

Abstract

The rat GnRH gene consists of four short exons (denoted 1, 2, 3, and 4) and three introns (A, B, and C). All three introns are spliced from the primary transcript, resulting in a mature mRNA. Northern blot and RT-PCR analyses showed that the GnRH primary transcript and its splicing intermediates are more prevalent than the mature GnRH mRNA in a variety of non-GnRH-producing tissues. To delineate the possible splicing mechanism of introns, an in vitro HeLa splicing system was used. Introns B and C were efficiently spliced, while intron A spanning between exon 1 and exon 2 was not. The retention of intron A was relieved when the 5'- and/or 3'-splice sites of intron A were point mutated based on the consensus sequence. The splicing activity was even more strengthened when a putative branchpoint site was moved to the upstream region of the pyrimidine tract of intron A. Intron A could be partially spliced when whole exons (2, 3, and 4) were linked up with intron A. There are two putative exonic splicing enhancers (ESEs) in exon 3 and exon 4. The ESE on exon 4 (ESE4) is much stronger than that on exon 3. The closer the ESE4 to the 3'-splice site of intron A, the better the splicing activity became. However, in the presence of the nuclear extract from GnRH neurons, there was an enhancement in the splicing activity notwithstanding the distance between ESE4 and 3'-splice site of intron A. These results suggest that the ESE4 functions as both the constitutive and regulated enhancer. Collectively, our study provides evidence that enhanced splicing of intron A by putative GnRH neuron-specific splicing factor(s) interacting with the ESEs is a prerequisite for mature GnRH synthesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551782     DOI: 10.1210/mend.13.11.0375

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

1.  Splicing of constitutive upstream introns is essential for the recognition of intra-exonic suboptimal splice sites in the thrombopoietin gene.

Authors:  M Romano; R Marcucci; F E Baralle
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

Review 2.  Gonadotropin-releasing hormone receptor system: modulatory role in aging and neurodegeneration.

Authors:  Liyun Wang; Wayne Chadwick; Sung-Soo Park; Yu Zhou; Nathan Silver; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

Review 3.  Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis.

Authors:  D C Skinner; A J Albertson; A Navratil; A Smith; M Mignot; H Talbott; N Scanlan-Blake
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

4.  Nova-1 mediates glucocorticoid-induced inhibition of pre-mRNA splicing of gonadotropin-releasing hormone transcripts.

Authors:  Eonyoung Park; Mi Sun Lee; Sun Mi Baik; Eun Bee Cho; Gi Hoon Son; Jae Young Seong; Kun Ho Lee; Kyungjin Kim
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

5.  Oxytocin and vasopressin gene expression and RNA splicing patterns in the rat supraoptic nucleus.

Authors:  Chunmei Yue; Todd A Ponzio; Raymond L Fields; Harold Gainer
Journal:  Physiol Genomics       Date:  2008-09-02       Impact factor: 3.107

6.  The Methylcytosine Dioxygenase Ten-Eleven Translocase-2 (tet2) Enables Elevated GnRH Gene Expression and Maintenance of Male Reproductive Function.

Authors:  Joseph R Kurian; Somaja Louis; Kim L Keen; Andrew Wolfe; Ei Terasawa; Jon E Levine
Journal:  Endocrinology       Date:  2016-07-06       Impact factor: 4.736

Review 7.  Development of the gonadotropin-releasing hormone system.

Authors:  Anne H Duittoz; Paolo E Forni; Paolo Giacobini; Matan Golan; Patrice Mollard; Ariel L Negrón; Sally Radovick; Susan Wray
Journal:  J Neuroendocrinol       Date:  2022-01-23       Impact factor: 3.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.